Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader
Li Chen, Yahui Zou, Renhong Sun, Mei Huang, Xiaotong Zhu, Xiao Tang, Xiaobao Yang, Dake Li, Gaofeng Fan, Yu Wang · 2024
Read Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader by Li Chen, Yahui Zou, Renhong Sun, Mei Huang, Xiaotong Zhu, Xiao Tang, Xiaobao Yang, Dake Li, Gaofeng Fan, Yu Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11655542.txt.
Description
Li Chen and co-authors design a drug that destroys a DNA-repair enzyme instead of just blocking it, aiming at safer cancer therapy, in a 2024 paper. The enzyme, PARP1, helps cells fix DNA, and tumors with broken backup repair die when it is blocked. Existing blockers also trap the enzyme on DNA, causing side effects. The team built a degrader, molecule 180055, that tags PARP1 for disposal.
The degrader removed PARP1 selectively and shut off its activity with no noticeable DNA trapping. It killed tumor cells carrying BRCA mutations while barely touching normal cells, in dishes and in animals. The authors present the compound as both potent and unusually safe. They argue it earns a path toward clinical testing.
Catalog record
| CREATOR | Li Chen, Yahui Zou, Renhong Sun, Mei Huang, Xiaotong Zhu, Xiao Tang, Xiaobao Yang, Dake Li, Gaofeng Fan, Yu Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |